Publications Office of the EU
Latvia-Riga: Immune sera and immunoglobulins - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Latvia-Riga: Immune sera and immunoglobulins

Overview
  • Announced
    13/06/2014
  • Published
    29/01/2015
  • Deadline
    26/02/2015
  • Opening of tenders
    26/02/2015
  • Awarded
    23/04/2015
  • Today
    03/10/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Nacionālais veselības dienests
Place of performance
NUTS code: LV006 Rīga
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33651500 Immune sera and immunoglobulins
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
313,700.00 EUR
Number of lots
5
Procedure details
Tender reference number
VM NVD 2014/13
Description

Purchase of immunobiological preparations for 2015.

Submission Method
Not available
Tenders may be submitted
Submission for one or more lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
Conditions for opening tenders (date)
26/02/2015 14:00
Place of performance
LV006 Rīga
CPV code

33651500 - Immune sera and immunoglobulins

Lots (5)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.